1. Home
  2. FNV vs WST Comparison

FNV vs WST Comparison

Compare FNV & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNV
  • WST
  • Stock Information
  • Founded
  • FNV 1986
  • WST 1923
  • Country
  • FNV Canada
  • WST United States
  • Employees
  • FNV N/A
  • WST N/A
  • Industry
  • FNV Precious Metals
  • WST Medical/Dental Instruments
  • Sector
  • FNV Basic Materials
  • WST Health Care
  • Exchange
  • FNV Nasdaq
  • WST Nasdaq
  • Market Cap
  • FNV 29.7B
  • WST 15.2B
  • IPO Year
  • FNV 2007
  • WST N/A
  • Fundamental
  • Price
  • FNV $165.30
  • WST $214.58
  • Analyst Decision
  • FNV Buy
  • WST Strong Buy
  • Analyst Count
  • FNV 8
  • WST 6
  • Target Price
  • FNV $163.43
  • WST $349.00
  • AVG Volume (30 Days)
  • FNV 1.1M
  • WST 1.0M
  • Earning Date
  • FNV 05-08-2025
  • WST 04-24-2025
  • Dividend Yield
  • FNV 0.92%
  • WST 0.39%
  • EPS Growth
  • FNV N/A
  • WST N/A
  • EPS
  • FNV 2.87
  • WST 6.37
  • Revenue
  • FNV $1,102,200,000.00
  • WST $2,895,800,000.00
  • Revenue This Year
  • FNV $28.02
  • WST $1.24
  • Revenue Next Year
  • FNV $19.06
  • WST $6.56
  • P/E Ratio
  • FNV $57.59
  • WST $33.44
  • Revenue Growth
  • FNV N/A
  • WST N/A
  • 52 Week Low
  • FNV $112.70
  • WST $187.43
  • 52 Week High
  • FNV $178.74
  • WST $372.79
  • Technical
  • Relative Strength Index (RSI)
  • FNV 50.87
  • WST 50.21
  • Support Level
  • FNV $163.50
  • WST $204.79
  • Resistance Level
  • FNV $172.00
  • WST $215.05
  • Average True Range (ATR)
  • FNV 4.27
  • WST 7.23
  • MACD
  • FNV -0.99
  • WST 1.16
  • Stochastic Oscillator
  • FNV 11.81
  • WST 63.32

About FNV Franco-Nevada Corporation

Franco-Nevada Corp is a precious-metals-focused royalty and investment company. The company owns a diversified portfolio of precious metals and royalty streams, which is actively managed to generate the bulk of its revenue from gold, silver, and platinum. The company does not operate mines, develop projects, or conduct exploration. Franco-Nevada's short-term financial performance is linked to the price of commodities and the amount of production from its portfolio of producing assets. Its long-term performance is affected by the availability of exploration and development capital. The company holds a portfolio of assets, diversified by commodity, revenue type, and stage of a project, located in the U.S, Canada, and Australia.

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

Share on Social Networks: